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Abstract
Objectives: To review immediate results, patency rates, hemodynamic success, and incidence of concomitant procedures with
external iliac artery stenting (EIAS). Methods: Demographic features, category and clinical grade, Trans-Atlantic Inter-Society Con
sensus II classification lesion type, pre- and postprocedure ankle-brachia! indices, and primary patency were compared between
group I (EIAS without distal revascularization) and group 2 (EIAS with concomitant distal revascularization). Results: No mortality
and a I00% immediate technical success rate was recorded in group I (n = 12) and group 2 (n = 24). Eleven patients (30.6%) also
had stenting of the adjacent common iliac artery. Two thirds of group 2 patients required concomitant femoral or distal revas
cularization. Condusions: No difference in stent patency rates was found between patients in group I versus group 2. Patients
requiring EIAS tend to have more diffuse arterial disease necessitating complicated open reconstruction and/or distal revascular
ization, as well as more proximal iliac stenting.
Keywords
stenting, iliac stenting, concomitant procedures

Introduction
For patients with aortoiliac occlusive disease, surgical revascu
larization has traditionally been the primary method for treat
ing disabling claudication or critical limb ischemia. The
success of endovascular therapies directed toward the Trans
Atlantic Inter-Society Consensus (TASC) A and B lesions has
now been recognized and in most cases regarded as preferable
to open surgical techniques. 1 While the initial T ASC guidelines
recommended an open surgical approach for the more complex
TASC C and D lesions, this has also been challenged in recent
reports, which propose an expanded role for endovascular
therapies in these lesions. 2• 5 However, not enough emphasis
has been placed on the fact that patients requiring external iliac
artery stenting (BIAS) have been noted to also need concomi
tant procedures either with common iliac artery stent (CIAS) or
with distal revascularization procedures.
The purpose of this study was to review immediate results,
patency rates, hemodynamic success, and incidence of conco
mitant procedures with BIAS at our institution.

December 2007. Thirty-six patients undergoing EIAS, with and
without concomitant distal revascularization, were included.
Demographic features, prevalence of risk factors, category and
clinical grade of vascular lesions (Rutherford classification),
TASC lesion type, and pre- and postprocedure ankle--brachial
indices (ABis) were recorded. Initial hemodynamic success
(defined as an increase of the ABI from preprocedure >0.15)
was measured for all patients. The patients were divided into
2 groups based on the procedure that was performed: group 1
(external iliac artery [EIA] stent without any additional proce
dures other than CIAS [n = 12]), and group 2 (EIA stent with a
concomitant distal intervention/bypass or a local reconstruction
in the groin [n = 24]). The 36 patients were further subdivided
into 4 subgroups based upon the exact procedure performed
(la) BIA stent only (n = 6); (lb) BIA and common iliac artery
(CIA) stent only (n = 6); (2a) EWCIA stent and distal
revascularization, including open or endovascular procedures
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A retrospective chart/electronic medical record review in the
Division of Vascular Diseases and Surgery at The Ohio State
University Medical Center was performed from June 2004 to
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Figure I • Distribution of risk factor.

(n = 20); (2b) EWCIA stent and limited procedures consisting
of mostly femoral endarterectomy with or without patches
(n = 6). Two patients had both distal revascularization and
femoral reconstruction.
Analysis of variance was used to determine whether the
differences existed in the technical success and primary
patency rates between the groups. This study was approved
bythe Institutional Review Board at the Ohio State University
Medical Center.
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The study population consisted of 6 women and 30 men. The
prevalence ofrisk factors were smoking (67.6%), hyperlipide
mia (59.5%), coronary artery disease (43%), diabetes (10.8%),
and hypertension (69.4%; Figure 1). The mean follow-up for
the entire cohort was 20.9 months (standard deviation ± 19.3).
Ofthe 36 patients, 11 patients (30.6%) also had stenting of
the ipsilateral CIA. No mortality was seen and a 100% techni
cal success rate was recorded in both groups. Patients in group
2 underwent concomitant 13 femoral-popliteal bypasses and 5
femoral-femoral bypass procedures. Six (16.6%) patients had
associated open femoral procedures consisting of endarterect
omy with or without a patch or a local interposition graft
(including 2 who had both).
The Rutherford classification ofdisease showed a predomi
nance ofcategory 3, class I lesions (n = 21 ). Anatomically, the
majority ofthe lesions were TASC B (n = 24; Figure 2). Pri
mary patency, as assessed by life-table analysis, was 100% for
the first 10 months after intervention (Figure 3).
Primary patency was also determined in each of the sub
groups. Primary patency was similar for groups la, 1b, and
2b. Group 2a (EI stent and concomitant distal revasculariza
tion) had primary patency rate similar to the other groups for
the first 10 months, then declined to 70% thereafter (Figure 4).
The average preprocedure ABI was 0.63 ± 0.25 and the
postprocedure ABI was 0.83 ± 0.25. Although the initial

2

0 -1--- - - -

Figure 2. Trans-Atlantic Inter-Society Consensus lesions by
distribution.

hemodynamic success was no different in groups 1 and 2, there
was a trend toward a greater improvement in postprocedural
ABI in group 2. Patients with TASC C lesions in group 2 exhib
ited a significantly greater improvement in postprocedural ABI
compared with TASC A and B lesions undergoing the same
treatment (P < .05).

Discussion
Prior to technical advancements in endovascular technology,
femoral disease extending proximally into the EIA was treated
with retroperitoneal endarterectomy, unilateral iliofemoral
bypass, or crossover femoral bypass. Patients with predomi
nantly unilateral atherosclerotic disease involving the iliofe
moral system are now uniquely suited to a combined
approach of iliac artery angioplasty/stenting with or without
open reconstruction ofthe femoral/profunda artery, sometimes
with distal revascularization as well. The argument against
extending iliac stents across the inguinal ligament into the
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Figure J, Primary patency rates for all patients undergoing external
iliac. artery stenting.

of our patients also required CIA stenting. In a study by Maurel
and colleagues, 90 patients treated with EIA stents were
followed up for a mean of 23 months.7 The primary patency
rate was 973, 89.7%, and 83.7% at l, 2, and 3 years, respec
tively. Lee et al compared the results ofEIA and CIA stenting
in patients with occlusive lesions. 8 In 49 patients with EIA
lesions, the primary patency rate following treatment was
933 and 90% versus 883 and 783 for CIA lesions at 1 year
and 3 years, respectively. Powell et al reported much less favor
able results after PTA and selective stenting for EIA lesions
with 47% and 18% primary patency rates at 12 and 36 months,
respectively.9 There are likely selection biases in some studies
reporting inferior patency rates with EIA interventions. These
biases include differences in severity of clinical ischemia,
stenting techniques, and types of stents. Although our series
does not directly compare CIA with EIA stents, patency rates
were not significantly different between patients with EIAS
alone and those with CIA and EIA stents.

Influence of TASC Classification on Outcomes
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Figure 4. Primary patency of the subgroups.

femoral area is that of stent fracture when crossing the inguinal
ligament as well as intimal hyperplasia due to external forces
on the vessel.6 The question remains as to whether external
iliac disease behaves more like CIA occlusive disease and is
easily treatable with percutaneous techniques or to infraingu
inal disease for which open surgical techniques may still be a
better option.

The BAS Results Compared With CIA Percutaneous
Transluminal Angioplasty (PTA)/Stenting
Because of the widely held belief that EIA PTA/stenting has a
lower long-term patency compared with CIA PTA/stenting, a
review of EIA endovascular intervention is reasonable. The
contiguous disease pattern is such that 73 to 663 of patients
reported in the literature who underwent EIA stents also
required CIA angioplasty/stent (Table 1). Thirty percentage

The TASC classification provides a standardized method of
anatomically describing arterial lesions as well as providing a
common framework for reporting outcomes following treat
ment. For totally occluded or severe and complex lesions ofthe
iliac arteries (TASC C or D), surgical intervention has been rec
ommended or preferred, whereas endovascular intervention has
been advocated for TASC A and B lesions.1 The majority of
patients (663) in our report had TASC B lesions. Although
patients with TASC C lesions had significantly greater rise in
immediate postprocedural ABI (0.27) compared with the other
2 groups (0.23 for TASC A lesions and 0.26 for TASC B lesions;
P < .05), there appeared to be no significant difference in
patency rates. Maurel and colleagues reported that 77.73 ofEIA
lesions treated by endovascular means were classified as TASC
A and B lesions.7 Like other authors they reported that TASC C
or D lesions were associated with a much higher risk ofresteno
sis.10 One of the reasons given for poorer outcomes in some
series with EIA lesions compared with CIA lesions treated with
stents is that patients with EIA lesions tend to have more severe
multisegmental disease (fASC C lesions.) This is supported in
our current series with one third requiring concomitant CIA
stenting and two third requiring concomitant distal revasculari
zation Only 6 patients underwent EIA stenting alone.
Primary patency has been reported to be significantly lower
11
in patients with TASC type C or D lesions. In a large series of
533 CIA and EIA lesions followed for a mean of 72 months,
693 were classified as TASC A and B, whereas 313 were
TASC C and D lesions. 12 The procedure time and complication
rate were both higher in the more severe TASC C and D groups.
However, no significant differences existed in initial and long
term patency between the 2 groups.
Whether the presence ofEIA disease, regardless ofseverity,
is a significant predictor of poor outcomes after angioplasty/
stenting in women has been debated7 •11 Timaran observed sig
nificantly worse results in women among a group of 67 patients
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Table I. Incidence of Concomitant Procedures in Patients Undergoing External Iliac Artery Stenting
Year
Reported
Pum•
Maurel
Nelsonb
Timaranc
Lee
Chan(
Kashyape
Authorsf

2011
2009
2002
2001
2000
2008
2008
2011

No. of Patients
(arteries)

223
90 (107)

34
67 (87)
69 (98)
171 (193)
83 (127)
36

Mean Follow-Up
(months)

Associated Common
Iliac Angioplasty/Stent

18
23
13
28
21
24
21
20.9

Associated Open
Femoral Procedures

N/A
20190 (22%)

4 (12%)
45/87 (51%)
7198 (7%)
104 (66%)

Associated lnfrainguinal
Bypass and/or Distal
Endovascular Procedures

261223 (8.5%)
8191 (12%)
36 (100%)

N/A

11 (30.6%)

NIA
NIA
NIA

12 (14.4%)
6 (16.6%)

171223 (7.6%)
2/91 (2%)
14 (41%)
551247 (22%)
NIA

52 (27%)
5 (4%)
20 (55%)

Abbreviations: El, external iliac; Cl, common iliac; FP, femoral-popliteal; N/A, not available.
• Serles Included El and Cl lesions.
b Series only included patients with El stenting and combined common femoral endarterectomy.
c Series reported additional concomitant procedures in entire cohort (common and external iliac stents).
d Series only included patients with El and Cl stanting and combined common femoral endarteractomy.
• Series compared aortofemoral reconstruction with angioplasty/stenting of both El and Cl arteries.
f Two patients had both associated open procedures and FP/distal endovascular procedures.

with claudication or critical limb ischemia treated with EIA
stenting with a primary patency rate of only 61 % and 47% at
1 and 3 years compared with a global rate of 763 and 563 for
the entire series. 11 Our numbers are too small to draw any con
clusions on the influence of gender in our cohort.

The overall experience in patients requiring EIA stenting is
that a significant number will also require CIA stenting, local
femoral reconstruction, or distal femoral endovascular or
bypass procedures. It behooves the vascular surgeon to be pre
pared to do more than EIA stenting in this group of patients.

Influence of Concomitant Distal Disease
Concomitant Procedures
Management of concomitant femoral artery and distal
nfrainguinal disease is an important consideration in patients
with aortoiliac disease. In a recent report, 503 of patients
required a local endarterectomy with or without a profunda
plasty and another 11 % needed simultaneous lower extremity
bypass in patients undergoing an aortofemoral bypass. 13 In the
same series, comparing open to endovascular intervention,
213 of the angioplasty/stent group required either femoral
reconstruction or a bypass. In our experience, 20 patients
(55%) underwent associated in:frainguinal bypass and/or distal
endovascular procedures and 6 (16.6%) also had an endarter
ectomy or an interposition graft. In a similar series of patients
with EIA stenting, 8 (123) of 91 patients had associated open
femoral or distal procedures performed7 In a recent report of
223 interventions for aortoiliac disease, concomitant open sur
gical procedures were performed in 26 patients (8.5%). 14 Eigh
teen underwent open femoral endarterectomy, 8 femoral
femoral, and 4 femoral--popliteal bypasses. In addition, an
associated endovascular procedure involving the femoral/
popliteal system was necessary in 17 patients.
One of the few reported experiences describing results with
EI stenting combined with concomitant femoral endarterectomy
was published by Nelson and colleagues. 15 Four (123) ofthe 34
patients in the series also needed CI angioplasty and 14 (413)
had distal revascularization performed. With a mean follow-up
period of 13 months, 1-year primary patency and primary
assisted patency rates were 84% and 97%, respectively.

The influence of associated distal disease on the clinical out
come ofiliac revascularization with either open surgical proce
dures or endovascular methods has been debated Stein
reported a clinical benefit of 23.3% at 4 years following aorto
femoral surgical bypass in patients with outflow disease com
pared with 84% in patients with good outflow. 16 Laborde et
al studied 455 patients comparing patients with aortoiliac dis
ease, external iliac disease, and multilevel disease to determine
outcomes. 17 The presence of associated distal disease was a
powerful predictor of unsatisfactory outcomes following iliac
stent placement. At 3 years, only 60.8% showed clinical suc
cess compared with 91.6% with aortoiliac/iliac disease and
97.9% with external iliac disease pattern. Ballard et al exam
ined the treatment ofTASC type D iliac lesions and found that
ipsilateral superficial femoral artery occlusion was an indepen
dent predictor of both bypass graft failure and stent failure. 18
Our experience with patients who require EWCIA stenting
with concomitant distal revascularization confirms that pri
mary patency dropped off after the first 10 months in contrast
to the other 3 subgroups (Figure 4).

Conclusion
In summary, our results show good technical and short-term
success with EIA stenting and concomitant CIA stenting and/
or distal revascularization. The use ofendovascular techniques
for TASC C and D lesions is still debated. The vascular surgeon
should be prepared to perform a local revascularization or
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distal procedure to improve outflow at the time ofEIA stenting
in overtwo thirds ofthis population. In addition, almost one third
ofpatients needing EIA stenting will need CIA stenting as well.
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